Ticker
TBPHCompany Name
THERAVANCE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Non-Current Debt |
---|---|
6/30/2025 | $ 35.56M |
3/31/2025 | $ 37.35M |
12/31/2024 | $ 39.11M |
9/30/2024 | $ 40.78M |
6/30/2024 | $ 42.44M |
3/31/2024 | $ 43.84M |
12/31/2023 | $ 45.24M |
9/30/2023 | $ 41.12M |
6/30/2023 | $ 42.52M |
3/31/2023 | $ 43.76M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Jun 30, 2025
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 2.42K |
---|---|
min | $ 0 |
max | $ 477.83M |
average | $ 67.33M |
median | $ 7.85M |
std | $ 114.95M |